Rani Therapeutics Holdings (RANI) Income from Non-Controlling Interests (2020 - 2025)
Historic Income from Non-Controlling Interests for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to -$2.5 million.
- Rani Therapeutics Holdings' Income from Non-Controlling Interests rose 5787.17% to -$2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.3 million, marking a year-over-year increase of 2790.86%. This contributed to the annual value of -$26.6 million for FY2024, which is 2166.43% up from last year.
- As of Q3 2025, Rani Therapeutics Holdings' Income from Non-Controlling Interests stood at -$2.5 million, which was up 5787.17% from -$4.5 million recorded in Q2 2025.
- In the past 5 years, Rani Therapeutics Holdings' Income from Non-Controlling Interests registered a high of -$2.5 million during Q3 2025, and its lowest value of -$25.6 million during Q3 2021.
- Moreover, its 5-year median value for Income from Non-Controlling Interests was -$7.3 million (2024), whereas its average is -$7.9 million.
- As far as peak fluctuations go, Rani Therapeutics Holdings' Income from Non-Controlling Interests crashed by 78650.71% in 2021, and later skyrocketed by 6770.87% in 2022.
- Quarter analysis of 5 years shows Rani Therapeutics Holdings' Income from Non-Controlling Interests stood at -$8.1 million in 2021, then decreased by 5.42% to -$8.6 million in 2022, then increased by 18.69% to -$7.0 million in 2023, then increased by 2.62% to -$6.8 million in 2024, then skyrocketed by 63.07% to -$2.5 million in 2025.
- Its Income from Non-Controlling Interests was -$2.5 million in Q3 2025, compared to -$4.5 million in Q2 2025 and -$5.5 million in Q1 2025.